Skip to main content

Table 5 Relationship between non-HDL-c/HDL-c ratio and reversion to normoglycemia in people with IFG in different models with competing risk of progression to diabetes

From: Association between non-high-density lipoprotein to high-density lipoprotein ratio and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study

Exposure

Model I (SHR, 95% CI, P)

Model II (SHR, 95% CI, P)

Model III (SHR, 95% CI, P)

Non-HDL-c/HDL-c ratio

0.74 (0.72, 0.76) < 0.0001

0.80 (0.78, 0.82) < 0.0001

0.71 (0.69, 0.74) < 0.0001

Non-HDL-c/HDL-c ratio Quartile

 Q1

Ref

Ref

Ref

 Q2

0.81 (0.76, 0.87) < 0.0001

0.89 (0.83, 0.95) 0.0009

0.81 (0.76, 0.87) < 0.0001

 Q3

0.58 (0.54, 0.62) < 0.0001

0.68 (0.64, 0.73) < 0.0001

0.58 (0.54, 0.63) < 0.0001

 Q4

0.47 (0.44, 0.50) < 0.0001

0.57 (0.53, 0.61) < 0.0001

0.45 (0.41, 0.49) < 0.0001

P for trend

 < 0.0001

 < 0.0001

 < 0.0001

  1. Model I: we did not adjust other covariates
  2. Model II: we adjust gender, age, BMI, SBP, DBP, family history of diabetes, smoking and drinking status
  3. Model III: we adjust gender, age, BMI, SBP, DBP, FPG, BUN, Scr, TG, LDL-c, ALT, AST, family history of diabetes, smoking and drinking status
  4. SHR subdistribution hazard ratios, CI confidence, Ref reference